Adnexus

Curated by Signal

Developer of proteins and monoclonal antibodies for the treatment of infectious diseases

Life Sciences Technologyadnexusbiotech.com

Overview

Developer of proteins and monoclonal antibodies for the treatment of infectious diseases. It offers AI-based platform that identify conserved and immutable targets for producing antibodies that target specific sites on viruses.

Key facts

Founded: 2024
Headquarters: Dallas, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

5 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

CDx Diagnostics
Provider of AI-based platform to detect precancerous tissues
Life Sciences TechnologySuffern, United States
NineLife
Digital marketplace offering a diverse range of health and wellness products
Life Sciences TechnologyLewes, United States
Active Motif
Provider of research kits, assays and biocomputing systems
Life Sciences TechnologyCarlsbad, United States

About Adnexus

What does Adnexus do?

Developer of proteins and monoclonal antibodies for the treatment of infectious diseases.

Where is Adnexus headquartered?

Adnexus is headquartered in Dallas, United States.

When was Adnexus founded?

Adnexus was founded in 2024.

Which sector is Adnexus in?

Adnexus operates in Life Sciences Technology.

Who are Adnexus's competitors?

Companies similar to Adnexus include CDx Diagnostics, NineLife, and Active Motif.